Prostate Cancer
Advances in PSMA-Targeted Radionuclide Therapeutics.
April 3, 2025
Darolutamide plus androgen-deprivation therapy: propensity score matching of ARASEC and historic clinical trial patients.
April 2, 2025
Racial variation in the advanced prostate cancer genome.
April 2, 2025
Causes of evolutionary divergence in prostate cancer.
April 2, 2025
Emulating an Existing Trial of Treatments for Prostate Cancer Using Real-World Data: Challenges and lessons learned.
April 1, 2025
Curium Completes the Acquisition of Monrol as Part of Its Plan to Significantly Expand Lutetium-177 Capacity and PET Footprint
March 31, 2025
The Role of 18F PSMA-1007 PET/CT in the Staging and Detection of Recurrence of Prostate Cancer, A Scoping Review.
March 31, 2025